American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
40.45
+0.06 (0.15%)
At close: Aug 15, 2025, 4:00 PM
40.74
+0.29 (0.72%)
After-hours: Aug 15, 2025, 6:09 PM EDT
American Healthcare REIT Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for American Healthcare REIT stock ranges from a low of $31 to a high of $45. The average analyst price target of $40.44 forecasts a -0.02% decrease in the stock price over the next year.
Price Target: $40.44 (-0.02%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 5 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $39 → $45 | Buy | Maintains | $39 → $45 | +11.25% | Aug 13, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $40 → $45 | Buy | Maintains | $40 → $45 | +11.25% | Aug 11, 2025 |
| Baird | Baird | Buy Initiates $41 | Buy | Initiates | $41 | +1.36% | Jul 18, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $42 | Buy | Initiates | $42 | +3.83% | Jun 30, 2025 |
| Keybanc | Keybanc | Buy Maintains $34 → $40 | Buy | Maintains | $34 → $40 | -1.11% | Jun 11, 2025 |
Financial Forecast
Revenue This Year
2.24B
from 2.06B
Increased by 8.30%
Revenue Next Year
2.39B
from 2.24B
Increased by 6.71%
EPS This Year
0.36
from -0.29
EPS Next Year
0.67
from 0.36
Increased by 83.33%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.4B | 2.7B | 2.9B |
| Avg | 2.2B | 2.4B | 2.6B |
| Low | 2.1B | 2.2B | 2.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 17.0% | 19.6% | 23.2% |
| Avg | 8.3% | 6.7% | 8.6% |
| Low | 2.6% | -0.3% | -1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.44 | 0.82 | 1.01 |
| Avg | 0.36 | 0.67 | 0.95 |
| Low | 0.26 | 0.47 | 0.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 125.2% | 51.2% |
| Avg | - | 83.3% | 42.4% |
| Low | - | 29.4% | 35.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.